Zomedica Corp.
ZOM was delisted on the 4th of March, 2025.
7 hedge funds and large institutions have $9.5K invested in Zomedica Corp. in 2026 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 3 closing their positions.
13% less funds holding
Funds holding: 8 → 7 (-1)
33% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 3
92% less capital invested
Capital invested by funds: $123K → $9.5K (-$113K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
EWA
EverSource Wealth Advisors
Birmingham,
Alabama
|
+$100 |
| 2 |
FFA
Farther Finance Advisors
San Francisco,
California
|
+$9 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JWM
Jackson Wealth Management
Lake Mary,
Florida
|
-$76K |
| 2 |
ASN
Advisory Services Network
Atlanta,
Georgia
|
-$35.3K |
| 3 |
SIS
Sound Income Strategies
Ft Lauderdale,
Florida
|
-$112 |
ZOM Hedge Fund Activity: Q2 2026 in Review
7 of the 8,305 institutional investors tracked by Wall St. Rank reported a position in Zomedica Corp. (ZOM) for Q2 2026, worth a combined $9.5K — down 92% from $123K a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of ZOM and 2 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 0 added.
The largest buyer was EverSource Wealth Advisors, opening a new position worth an estimated $100. The largest seller was Jackson Wealth Management, exiting entirely with an estimated $76K sold.
- 7 institutional investors held Zomedica Corp. (ZOM) as of Q2 2026, down from 8 in Q1 2026.
- Funds reported $9.5K of Zomedica Corp. stock for Q2 2026, down 92% quarter-over-quarter.
- 2 funds opened new Zomedica Corp. positions in Q2 2026 and 3 closed out, a net change of -1 holder.
- The largest Zomedica Corp. buyer in Q2 2026 was EverSource Wealth Advisors, an estimated $100 added.
- The largest Zomedica Corp. seller in Q2 2026 was Jackson Wealth Management, an estimated $76K sold.
Based on aggregated 13F filings for Q2 2026.